{
    "Trade/Device Name(s)": [
        "MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime/Avibactam"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K172337",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162740"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "JWY",
        "LRG",
        "LTW"
    ],
    "Summary Letter Date": "August 1, 2017",
    "Summary Letter Received Date": "August 2, 2017",
    "Submission Date": "October 27, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime/Avibactam susceptibility",
        "Citrobacter freundii complex",
        "Citrobacter koseri",
        "Enterobacter aerogenes",
        "Enterobacter cloacae",
        "Escherichia coli",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae",
        "Morganella morganii",
        "Proteus mirabilis",
        "Pseudomonas aeruginosa",
        "Providencia rettgeri",
        "Providencia stuartii",
        "Serratia marcescens"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan instrumentation",
        "autoSCAN-4 instrument",
        "WalkAway system"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Dehydrated panel rehydrated with water",
        "Manual or instrument readout"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Dried Gram-Negative MIC/Combo Panels with addition of ceftazidime/avibactam for antimicrobial susceptibility testing of gram-negative bacilli.",
    "Indications for Use Summary": "Quantitative and/or qualitative determination of antimicrobial agent susceptibility for rapidly growing aerobic and facultative anaerobic gram-negative bacilli using dried panel with ceftazidime/avibactam.",
    "fda_folder": "Microbiology"
}